ARH (N = 155) | RRH1 ('06–'12) (N = 77) | RRH2 ('13–'18) (N = 91) | P | |
---|---|---|---|---|
Depth of invasion | 0.8 ± 0.5 | 0.6 ± 0.6 | 0.5 ± 0.5 | < 0.001 |
LVSI | 55 (50.5%) | 21 (27.3%) | 19 (20.9%) | < 0.001 |
Harvested pelvic LNs | 19.7 ± 9.8 | 16.6 ± 9.2 | 9.6 ± 9.0 | < 0.001 |
LN metastasis | 16 (11.3%) | 4 (5.2%) | 9 (9.9%) | 0.188 |
Tumor size | 1.7 ± 1.4 | 2.0 ± 1.1 | 2.4 ± 1.7 | 0.014 |
Postoperative treatment | 0.001 | |||
RT | 28 (19.7%) | 5 (6.5%) | 4 (4.4%) | |
POAC | 9 (6.3%) | 6 (7.8%) | 1 (1.1%) | |
CCRT | 9 (6.3%) | 7 (9.1%) | 11 (12.1%) |